Accelerated approval drug labels often lack information for clinical decision-making

Ballreich, J; Socal, M; Bennett, CL; Xuan, A; Trujillo, A; Anderson, G

Ballreich, J (通讯作者),Johns Hopkins Bloomberg Sch Publ Hlth, Hlth Econ & Outcomes Res Program, Baltimore, MD 21205 USA.

PHARMACOTHERAPY, 2023; 43 (4): 300

Abstract

Study objective: We evaluated US Food and Drug Administration labels for drugs approved under the accelerated approval pathway and whether these label......

Full Text Link